ETS1 and neoplasm: Additionally, univariate analysis demonstrated that a higher ETS1 expression level (HR = 1.65; 95% CI = 1.17–2.34; p = 0.005), a larger tumour size (HR = 1.49; 95% CI = 1.20–1.83; p = 0.018), and a higher clinical T stage (HR = 1.86; 95% CI = 1.31–2.36; p = 0.015) were markedly associated with overall survival.